Masahito Shimojo

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Nucleic acids research

Cancer cell international

Scientific reports

Osaka University

Nagasaki University Graduate School (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Osaka University

Japan

Specially Appointed Associate Professor :: Pharmaceutical Sciences

Osaka Medical College

Japan

Assistant Professor

Kansai Medical University

Japan

Assistant Professor :: Medical Chemistry

University of Kentucky College of Medicine

United States

Assistant Professor :: Molecular and Cellular Biochemistry

University of Kentucky College of Medicine

United States

Research Associate :: Molecular and Cellular Biochemistry

University of Kentucky College of Medicine

United States

Postdoctoral Fellow :: Biochemistry

Education History

Nagasaki University Graduate School

Japan

PHD :: Pharmaceutical Sciences

Nagasaki University Graduate School

Japan

MSC :: Pharmaceutical Sciences

Nagasaki University

Japan

BSC :: School of Pharmaceutical Sciences

Publications

Hiroto Kohashi, Ryu Nagata, Yusuke Tamenori, Tomorrow Amatani, Yoshifumi Ueda, Yasuo Mori, Yuuya Kasahara, Satoshi Obika, Masahito Shimojo
A novel transient receptor potential C3/C6 selective activator induces the cellular uptake of antisense oligonucleotides. Nucleic acids research 52 (9) (2024)
Hiroto Kohashi, Ryu Nagata, Yusuke Tamenori, Tomorrow Amatani, Yoshifumi Ueda, Yasuo Mori, Yuuya Kasahara, Satoshi Obika, Masahito Shimojo
A novel transient receptor potential C3/C6 selective activator induces the cellular uptake of antisense oligonucleotides. Nucleic acids research 52 (9) (2024)
Hiroto Kohashi, Ryu Nagata, Yusuke Tamenori, Tomorrow Amatani, Yoshifumi Ueda, Yasuo Mori, Yuuya Kasahara, Satoshi Obika, Masahito Shimojo
A novel transient receptor potential C3/C6 selective activator induces the cellular uptake of antisense oligonucleotides. Nucleic acids research 52 (9) (2024)
Hiroto Kohashi, Ryu Nagata, Yusuke Tamenori, Tomorrow Amatani, Yoshifumi Ueda, Yasuo Mori, Yuuya Kasahara, Satoshi Obika, Masahito Shimojo
A novel transient receptor potential C3/C6 selective activator induces the cellular uptake of antisense oligonucleotides. Nucleic acids research 52 (9) (2024)
Hiroto Kohashi, Ryu Nagata, Yusuke Tamenori, Tomorrow Amatani, Yoshifumi Ueda, Yasuo Mori, Yuuya Kasahara, Satoshi Obika, Masahito Shimojo
A novel transient receptor potential C3/C6 selective activator induces the cellular uptake of antisense oligonucleotides. Nucleic acids research (2024)
Misa Yoshida, Chihiro Oda, Keishiro Mishima, Itsuki Tsuji, Satoshi Obika, Masahito Shimojo
An antisense amido-bridged nucleic acid gapmer oligonucleotide targeting SRRM4 alters REST splicing and exhibits anti-tumor effects in small cell lung cancer and prostate cancer cells. Cancer cell international 23 (1) (2023)
Misa Yoshida, Chihiro Oda, Keishiro Mishima, Itsuki Tsuji, Satoshi Obika, Masahito Shimojo
An antisense amido-bridged nucleic acid gapmer oligonucleotide targeting SRRM4 alters REST splicing and exhibits anti-tumor effects in small cell lung cancer and prostate cancer cells. Cancer cell international 23 (1) (2023)
Masahito Shimojo, Yuuya Kasahara, Masaki Inoue, Shin-Ichi Tsunoda, Yoshie Shudo, Takayasu Kurata, Satoshi Obika
A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer. Scientific reports 9 (1) (2019)

Masahito Shimojo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masahito Shimojo